Brain-Derived Neurotrophic Factor Expression in Asthma. Association with Severity and Type 2 Inflammatory Processes

Area of Science:

• Neuroscience
• Immunology
• Respiratory Medicine

Background:

• Brain-derived neurotrophic factor (BDNF) is crucial for neuronal and immune cell function.
• The specific role of BDNF isoforms in asthma pathogenesis is not well understood.

Purpose of the Study:

• To compare BDNF protein isoforms and splice variant expression in asthma patients and healthy controls.
• To investigate the relationship between BDNF changes and asthma severity and type 2 inflammation.
• To examine IL-13's effect on BDNF expression in human airway epithelial cells.

Main Methods:

• Analysis of sputum and bronchoscopic samples from healthy and asthma participants.
• Measurement of total BDNF protein (ELISA, Western blot) and BDNF mRNA (PCR).
• In vitro study of IL-13 stimulated primary human airway epithelial cells.

Main Results:

• Mature BDNF isoform was significantly higher in sputum of severe asthma patients compared to controls.
• Total BDNF levels correlated with fractional exhaled nitric oxide and sputum eosinophilia.
• IL-13 stimulation in vitro increased specific BDNF splice variants and mRNA ratios.

Conclusions:

• Mature BDNF isoform and a specific splice variant (exon VIb) are elevated in asthmatic airways.
• Type 2 cytokines, like IL-13, may regulate BDNF levels and activity in asthma.